Notification That Annual Report Will Be Submitted Late (nt 10-k)
December 30 2015 - 6:05AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION |
Washington, D.C. 20549 |
|
FORM 12b-25 |
|
|
NOTIFICATION OF LATE FILING |
|
x Form 10-K |
o Form 20-F |
o Form 11-K |
o Form 10-Q |
o Form 10-D |
o Form N-SAR |
o Form N-CSR |
|
|
|
|
|
For period ended: |
September 30 , 2015 |
|
o Transition Report on Form 10-K |
|
|
o Transition Report on Form 20-F |
|
|
o Transition Report on Form 11-K |
|
|
o Transition Report on Form 10-Q |
|
|
o Transition Report on Form N-SAR |
|
|
For the Transition Period Ended: N/A |
Nothing in this form shall be construed to imply that
the Commission has verified any information contained herein.
If the notification relates to a portion of the filing checked
above, identify the Item(s) to which the notification relates:
PART I - REGISTRANT INFORMATION |
|
|
|
Bio-Matrix
Scientific Group, Inc |
|
Full Name of Registrant |
|
|
|
|
|
Former Name if Applicable |
|
|
|
4700 Spring Street, Suite 304 |
|
Address of Principal Executive Office (Street and Number) |
|
|
|
La Mesa, CA 91942 |
|
City, State and Zip Code |
|
PART II - RULES 12b-25 (b) AND (c)
If the subject report could not be filed without unreasonable
effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed.
|
(a) |
The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
x |
(b) |
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and |
|
(c) |
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached, if applicable. |
PART III - NARRATIVE
The Company could not complete the filing of its Annual Report
on Form 10-K for the period ended September 30, 2015 due to a delay in completion of the independent audit of the financial
statements required to be included in the Company's Form 10-K, which delay could not be eliminated by the Company without unreasonable
effort and expense. In accordance with Rule 12b-25 of the Securities Exchange Act of 1934, as amended, the Company will file its
Form 10-K no later than the fifteenth calendar day following the prescribed due date.
PART IV - OTHER INFORMATION
(1)
Name and telephone number of person to contact in regard to this notification: |
|
|
|
|
|
David Koos |
|
(619) |
|
702-1404 |
(Name) |
|
(Area Code) |
|
(Telephone Number) |
(2)
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). |
(3)
Is it anticipated that any significant change in results
of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included
in the subject report or portion thereof?
If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
|
|
|
|
Bio-Matrix
Scientific Group, Inc |
|
|
(Name
of Registrant as Specified in Charter) |
|
has caused this notification to be signed on its behalf by
the undersigned hereunto duly authorized.
Date: December 29, 2015 |
By: |
/s/ David Koos |
|
|
|
David Koos |
|
|
|
President & Chief
Executive Officer |